Stock Market News 16 December 2025

Nebius Group (NBIS) Stock Slides as AI “Neocloud” Volatility Returns: News, Forecasts and Analysis for Dec. 16, 2025

Nebius Group N.V. (NASDAQ: NBIS) shares were lower on Tuesday, December 16, 2025, extending a recent pullback that has split Wall Street into two camps: investors who see Nebius as a scarce, high-demand “AI infrastructure” winner, and skeptics who argue the stock’s fundamentals can’t yet justify the volatility and valuation. As of the latest trade Tuesday, NBIS was around $78.54, down about 3.2% on the day, with an intraday range of roughly $76.95 to $81.88 and volume near 9.5 million shares. That decline follows a sharp drop in the prior session: MarketBeat reported NBIS fell 7.5% on Monday to about

16 December 2025

Financial Forecasts·NASDAQ:NBIS·Stock Market

SoFi Stock (SOFI) News Today: $1.5B Share Offering Fallout, Analyst Targets, and 2026 Forecasts (Dec. 16, 2025)

SoFi Technologies, Inc. (NASDAQ: SOFI) is back in focus on Tuesday, December 16, 2025, as investors weigh a December equity raise, fresh product rollouts, and a growing stack of mixed analyst calls heading into 2026. Shares traded around $26.16 in the latest data Tuesday, up about 1.3% from the prior close, after ranging between roughly $25.42 and $26.74 during the session. The stock remains about 20% below its $32.73 all-time high set on November 12, 2025, underscoring how quickly sentiment can swing in high-beta fintech names. TradingView Below is a detailed rundown of the key news, forecasts, and analyses circulating

16 December 2025

NASDAQ:SOFI·Stock Market

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics Incorporated (NASDAQ: CORT) ended Tuesday, December 16, 2025, sharply lower after a strong 2025 run that had pushed expectations—and valuation—into the spotlight. Shares closed at $79.44, down $7.86 (about 9%) from the prior close, after trading as low as $78.84 on the day. The day’s narrative around Corcept Therapeutics stock wasn’t driven by a single blockbuster headline like an FDA decision or a clinical-trial halt. Instead, it was a classic “high-expectations” session: fresh sell-side coverage, valuation-focused commentary, and investors recalibrating risk ahead of a major FDA catalyst for relacorilant later this month. Below is a complete roundup of

16 December 2025

Biotechnology·NASDAQ:CORT·Pharmaceutical Industry·Stock Market

PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy Inc. stock (NYSE:PBF) is having a rough session on Tuesday, December 16, 2025, with shares trading around $27.13, down roughly 9% on the day after opening near $29.28 and touching an intraday range of about $26.85 to $29.37. Investing.com That kind of drop isn’t usually about one single headline. For refiners like PBF, the market often reacts to a messy cocktail of factors—operational incidents, regulatory scrutiny, and the broader crude/product price backdrop. Today’s flow of reporting fits that pattern, especially with fresh attention on PBF-linked refinery developments and a generally softer tone in energy tied to falling oil

16 December 2025

Energy Sector·NYSE:PBF·Stock Market

Amgen Stock (AMGN) News Today, Dec. 16, 2025: Dividend Boost, FDA Wins, Analyst Targets, and Key 2026 Catalysts

Amgen Inc. (NASDAQ: AMGN) is in focus on December 16, 2025, as investors weigh a fresh dividend raise, recent regulatory momentum, and a pipeline narrative that stretches from cardiovascular outcomes to the high-stakes obesity race. As of Dec. 16, 2025 (18:00 UTC), Amgen shares traded around $324.36, slightly lower on the day, with an intraday range roughly between $323.05 and $326.03. While price action is calm, the story around AMGN is busy—especially for long-term investors looking for a blend of income, defensiveness, and late-stage catalysts. What’s driving Amgen stock on Dec. 16: dividends back in the spotlight A key theme

16 December 2025

Dividends·NASDAQ:AMGN·Stock Market

Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Corporation (NASDAQ: SANM) stock fell sharply in Tuesday trading, even as the company unveiled two growth-oriented moves aimed at the U.S. power-grid equipment market: a new, state-of-the-art energy-focused factory planned for Houston and a transformer co-design agreement with Croatia’s Končar Group. At last check on Dec. 16, SANM shares were down about 8.85% at $144.17, after swinging between an intraday high of $159.98 and a low of $144.17. The market’s reaction highlights a familiar tension in “build for the future” announcements: investors may like the destination, but they immediately start interrogating the travel budget—capital spending, cash flow timing, and

16 December 2025

NASDAQ:SANM·Stock Market

AbbVie Stock (ABBV) News, Forecasts and Analysis for Dec. 16, 2025: BofA Trims Target as Pipeline Catalysts Stay in Focus

AbbVie Inc. (NYSE: ABBV) is trading lower on Tuesday, December 16, 2025, after a strong run earlier in the quarter and a Monday close that kept the stock near the upper end of its 52‑week range. As of 17:54 UTC on Dec. 16, ABBV was at $222.44, down $5.01 (-2.20%) on the session, with an intraday range of $222.44 to $228.00. Today’s AbbVie coverage is being driven less by a single blockbuster headline and more by the familiar mix of Wall Street recalibration and pipeline expectations: Bank of America trimmed its price target, while fresh pipeline-focused analysis reiterated the thesis

16 December 2025

NYSE:ABBV·Pharmaceutical Industry·Stock Market

Amkor Technology (AMKR) Stock Drops on Dec. 16, 2025: Latest News, Forecasts, and What Investors Are Watching

Amkor Technology, Inc. (NASDAQ: AMKR) is having a rough session on Tuesday, Dec. 16, 2025, with shares sliding sharply after a recent run-up. As of the latest available trade timestamp, AMKR was $39.89, down $4.02 (-9.16%) on the day, after trading between $43.88 (intraday high) and $39.89 (intraday low). That kind of move can feel like the floor suddenly became a trapdoor. But for Amkor, today’s volatility lands in the middle of a bigger story: advanced packaging becoming one of the most strategically important choke points in semiconductors—especially as AI and high-performance computing push the industry toward more complex “multi-chip”

16 December 2025

NASDAQ:AMKR·Stock Market

Vertiv (VRT) Stock News Today (Dec. 16, 2025): Why Shares Fell, What Analysts Forecast, and What to Watch Next

Vertiv Holdings (often listed as Vertiv Holdings Co. / “Vertiv Holdings, LLC Class A” on market platforms) is ending 2025 with a very familiar investor debate: AI data-center infrastructure demand looks strong, but the stock’s valuation has become a lightning rod. Nasdaq+1 On Tuesday, December 16, 2025, Vertiv shares closed around $158 after another volatile stretch. The stock’s day range was roughly $154.65–$162.47, and the session marked a ~2%+ decline on the day. StockAnalysis+1 That move follows a sharp pullback earlier in the month—including a nearly 10% drop on Dec. 12—as investors reacted to a prominent analyst downgrade, “index inclusion”

16 December 2025

NYSE:VRT·Stock Market

KLA Corporation (KLAC) Stock News Today: Cantor Upgrade, Jefferies $1,500 Target and AI Chip-Equipment Forecasts (Dec. 16, 2025)

KLA Corporation stock (NASDAQ: KLAC) is back in the spotlight on December 16, 2025, as a fresh wave of bullish analyst calls collides with new industry forecasts that point to a multi-year upcycle in chipmaking equipment—one that’s increasingly tied to AI-driven demand. KLAC traded around $1,224 in the latest available session check on Tuesday, keeping the stock close to recent highs after a strong move earlier this week following a high-profile Wall Street upgrade (and while investors digest an insider filing that’s drawing attention, even if it’s routine in nature). Below is what’s moving KLA stock today, what analysts are

16 December 2025

NASDAQ:KLAC·Stock Market

Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is seeing a sharp pullback in Tuesday trading (Dec. 16, 2025), with shares recently changing hands around $62—down roughly 9% from the prior close—after hitting an intraday low near $59.76. That drop may look dramatic in isolation, but it’s landing on top of an unusually eventful stretch for the RNA interference (RNAi) biotech: Arrowhead just transitioned into a commercial-stage story after its first FDA approval, picked up an FDA Breakthrough Therapy designation for a follow-on indication, and kicked off a new Alzheimer’s-related clinical program—three ingredients that tend to increase both upside narratives and day-to-day volatility

16 December 2025

NASDAQ:ARWR·Pharmaceuticals·Stock Market

Compass Inc stock COMP: Latest news, analyst forecasts, and key catalysts on December 16 2025

Compass Inc stock (NYSE: COMP) is back in the spotlight on December 16, 2025, as investors juggle a cocktail of real-estate industry disruption, Big Tech “portal wars,” and a major consolidation bet that could reshape U.S. residential brokerage. By midday Tuesday, COMP was trading around $10.76 after opening at $10.42, with an intraday range roughly $10.28–$10.76 on volume above 2.3 million shares. That price action matters because it comes immediately after a sharp volatility spike tied to a single unnerving question: What happens to real-estate search traffic (and lead economics) if Google decides it wants a bigger slice? Below is

16 December 2025

NYSE:COMP·Stock Market

Previous 1 … 1,232 1,233 1,234 1,235 1,236 … 1,946 Next

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026

IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026

Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.

Amazon stock slides on $200 billion AI spending plan — what to know before Monday’s open

7 February 2026

Amazon shares fell 5.55% to $210.32 Friday after the company outlined a $200 billion 2026 capex plan and forecast lower-than-expected operating income. D.A. Davidson downgraded the stock, citing tougher cloud competition. Analysts trimmed price targets following the results. Amazon reported Q4 net sales of $213.4 billion and AWS revenue of $35.6 billion.

AT&T stock price: T slips after $6.5B bond sale as payrolls, CPI loom next week

7 February 2026

AT&T shares closed down 0.7% at $27.13 on Friday, underperforming the S&P 500’s 1.97% gain. The company completed a $6.5 billion global notes sale this week, with maturities from 2031 to 2056 and coupons between 4.4% and 6%. Investors await delayed U.S. jobs and inflation data, along with T-Mobile’s upcoming earnings update.

Stock Market News 16 December 2025

Stock Market Today